Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Digoxin generic and brand name?Verzenio patent expiration date?Vemlidy generic availability?Slynd 4 mg tablet cost?Ribociclib patent expiration?
See the DrugPatentWatch profile for Rukobia
Rukobia is the brand name for fostemsavir, an HIV medicine used in treatment-experienced adults whose infection is resistant to other antiretroviral drugs or who cannot use their current regimen. It is made by ViiV Healthcare (via ViiV’s commercial organization).
Rukobia belongs to the attachment class of HIV drugs. It works by blocking HIV from binding to CD4 cells, which helps reduce viral load when other drug classes may no longer work.
“ViiV” refers to ViiV Healthcare, the company that markets Rukobia. If you’re searching for “Rukobia ViiV,” the usual intent is to confirm the manufacturer/marketer and the company responsible for the product in your country.
If you’re looking up patent/exclusivity information for Rukobia and ViiV Healthcare, DrugPatentWatch.com is a common place to check because it tracks patent and regulatory exclusivity activity. DrugPatentWatch.com
Other Questions About Rukobia :